[1] Xu C,
Wang W, Wang B, et al. Analytical methods and biological activities of Panax
notoginseng saponins: recent trends[J]. J Ethnopharmacol, 2019, 236:443-465.
DOI: 10.1016/j.jep.2019.02.035.
[2] Duan L, Xiong X, Hu J, et al. Efficacy
and safety of oral Panax notoginseng saponins for unstable angina patients: a
meta-analysis and systematic review[J]. Phytomedicine, 2018, 47:23-33. DOI:
10.1016/j.phymed.2018.04.044.
[3] 赵梦蕊,李勇.纤溶酶联合血栓通注射液治疗急性缺血性脑卒中疗效和安全性的Meta分析[J].中国药房,2017,28(27):3813-3816.
DOI:10.6039/j.issn.1001-0408.2017.27.19.
[4] 袁敏,黄利,游惠芬,等.复方血栓通胶囊治疗青光眼视神经萎缩患者的效果及对眼血流动力学的影响分析[J].国际医药卫生导报,2019,25(14):2363-2365.
DOI:10.3760/cma.j.issn.1007-1245.2019.12.050.
[5] 梁峰,沈珠军,方全,等.2014年美国心脏协会/美国心脏病学院关于非ST抬高急性冠脉综合征患者治疗指南(二)[J].中国心血管病研究,2015,13(8):689-692.
DOI:10.3969/j.issn.1672-5301.2015.08.005.
[6] Geovanini GR, Libby P. Atherosclerosis
and inflammation: overview and updates[J]. Clin Sci (Lond), 2018,
132(12):1243-1252. DOI: 10.1042/CS20180306.
[7] Gisterå A, Hansson GK. The immunology of
atherosclerosis[J]. Nat Rev Nephrol, 2017, 13(6):368-380. DOI:
10.1038/nrneph.2017.51.
[8] Hirahara K, Nakayama T. CD4+ T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm[J]. Int
Immunol, 2016, 28(4):163-171. DOI: 10.1093/intimm/dxw006.
[9] Rahimi K, Ahmadi A, Hassanzadeh K, et
al. Targeting the balance of T helper cell responses by curcumin in
inflammatory and autoimmune states[J]. Autoimmun Rev, 2019, 18(7):738-748. DOI:
10.1016/j.autrev.2019.05.012.
[10] Zaremba YH, Smaliukh OV,
Zaremba-Fedchyshyn OV, et al. Indicators of inflammation in the pathogenesis of
unstable angina[J]. Wiad Lek, 2020, 73(3):569-573.
[11] Ruggio A, Pedicino D, Flego D, et al.
Correlation between CD4+CD28null T lymphocytes,
regulatory T cells and plaque rupture: an optical coherence tomography study in
acute coronary syndromes[J]. Int J Cardiol, 2019, 276:289-292. DOI:
10.1016/j.ijcard.2018.08.101.
[12] Zara C, Severino A, Flego D, et al.
Indoleamine 2,3-dioxygenase (IDO) enzyme links innate immunity and altered
T-cell differentiation in non-ST segment elevation acute coronary syndrome[J].
Int J Mol Sci, 2017, 19(1):63. DOI: 10.3390/ijms19010063.
[13] Ding JW, Zhou T, Zheng XX, et al. The
effects of high mobility group Box-1 protein on peripheral Treg/Th17 balance in
patients with atherosclerosis[J]. Acta Cardiol Sin, 2018, 34(5):399-408. DOI:
10.6515/ACS.201809_34(5).20180419A.
[14] 李晓辉,成光宇,崔俊峰,等.基于整合药理学平台探讨三七治疗冠心病心绞痛的分子机制[J].中国老年学杂志,2020,40(12):2465-2470. DOI:10.3969/j.issn.1005-9202.
2020. 12.001.
[15] 高阳,吕健,谢雁鸣,等.血栓通(冻干粉)注射液治疗冠心病不稳定性心绞痛随机对照试验的有效性及安全性系统评价/Meta分析[J].中国中药杂志,2019,44(20):4366-4378.
DOI:10.19540/j.cnki.cjcmm.20190724.501.
[16] 王泰然,马巍.血栓通注射液对不稳定性心绞痛患者血清IL-6及MMP-2的影响[J].中国医药导报,2018,15(15):127-130.
|